N. Kumarasamy - Concepedia

Author

N. Kumarasamy

YR Gaitonde Centre for AIDS Research and Education

Also Known As

Egger, M., N Kumarasamy, N. Kumarasamy, Nagalingeswaran Kumarasamy, S. S. Solomon

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

YR Gaitonde Centre for AIDS Research and Education Brown University UNSW Sydney Miriam Hospital Ramathibodi Hospital

About

N. Kumarasamy is an author at YR Gaitonde Centre for AIDS Research and Education specializing in hiv, sexual health, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	170
2	Public Health	3	3	122
3	Social Sciences	2	2	61
4	Health Sciences	1	1	32
5	Nursing	1	1	32

N. Kumarasamy

Publications

835

Citations

H-Index

Page 1

	Year	Citations
Incidence of Immune Reconstitution Syndrome in HIV/Tuberculosis-Coinfected Patients After Initiation of Generic Antiretroviral Therapy in India N. Kumarasamy, Sreekanth K. Chaguturu, Kenneth H. Mayer, JAIDS Journal of Acquired Immune Deficiency Syndromes	2004	143
Total Lymphocyte Count (TLC) Is a Useful Tool for the Timing of Opportunistic Infection Prophylaxis in India and Other Resource-Constrained Countries N. Kumarasamy, Anish P. Mahajan, Timothy Flanigan, JAIDS Journal of Acquired Immune Deficiency Syndromes	2002	97
ART adherence, demographic variables and CD4 outcome among HIV-positive patients on antiretroviral therapy in Chennai, India Steven A. Safren, N. Kumarasamy, Romola James, AIDS Care	2005	83
High Frequency of Clinically Significant Mutations after First‐Line Generic Highly Active Antiretroviral Therapy Failure: Implications for Second‐Line Options in Resource‐Limited Settings N. Kumarasamy, Vidya Madhavan, Kartik K. Venkatesh, Clinical Infectious Diseases Drug Resistance MutationsTreatment And PreventionHuman RetrovirusImmunodeficienciesActive Antiretroviral Therapy	2009	65
Predictors of Nonadherence to Highly Active Antiretroviral Therapy Among HIV-Infected South Indians in Clinical Care: Implications for Developing Adherence Interventions in Resource-Limited Settings Kartik K. Venkatesh, Aylur Kailasom Srikrishnan, Kenneth H. Mayer, AIDS Patient Care and STDs Adherence InterventionsPharmacotherapyPreventive MedicineHiv/aids CounsellingVaccine Trial	2010	61
Experience with the use of a first‐line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database Jialun Zhou, NI Paton, Rossana Ditangco, HIV Medicine	2007	53
Gender-Based Differences in Treatment and Outcome among HIV Patients in South India N. Kumarasamy, Kartik K. Venkatesh, A. J. Cecelia, Journal of Women s Health	2008	45
Evaluation of two human immunodeficiency virus-1 genotyping systems: ViroSeq™ 2.0 and an in-house method Shanmugam Saravanan, P. Balakrishanan, N. Kumarasamy, Journal of Virological Methods Viroseq™ 2.0Human RetrovirusImmunodeficienciesImmunologyAntiviral Therapy	2009	44
Predicting short‐term disease progression among HIV‐infected patients in Asia and the Pacific region: preliminary results from the TREAT Asia HIV Observational Database (TAHOD) Jialun Zhou, N. Kumarasamy HIV Medicine	2005	43
Changes in Total Lymphocyte Count as a Surrogate for Changes in CD4 Count Following Initiation of HAART: Implications for Monitoring in Resource-Limited Settings Anish P. Mahajan, Joseph W. Hogan, Bradley S. Snyder, JAIDS Journal of Acquired Immune Deficiency Syndromes	2004	41

Page 1